JP2024542145A5 - - Google Patents

Info

Publication number
JP2024542145A5
JP2024542145A5 JP2024526929A JP2024526929A JP2024542145A5 JP 2024542145 A5 JP2024542145 A5 JP 2024542145A5 JP 2024526929 A JP2024526929 A JP 2024526929A JP 2024526929 A JP2024526929 A JP 2024526929A JP 2024542145 A5 JP2024542145 A5 JP 2024542145A5
Authority
JP
Japan
Prior art keywords
methyl
amino
imidazole
benzo
benzimidazole
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024526929A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024542145A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/048973 external-priority patent/WO2023081367A2/en
Publication of JP2024542145A publication Critical patent/JP2024542145A/ja
Publication of JP2024542145A5 publication Critical patent/JP2024542145A5/ja
Pending legal-status Critical Current

Links

JP2024526929A 2021-11-05 2022-11-04 Prmt5阻害剤としての2-アミノイミダゾール誘導体 Pending JP2024542145A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202163276479P 2021-11-05 2021-11-05
US63/276,479 2021-11-05
US202263356861P 2022-06-29 2022-06-29
US63/356,861 2022-06-29
PCT/US2022/048973 WO2023081367A2 (en) 2021-11-05 2022-11-04 2-amino imidazole derivatives

Publications (2)

Publication Number Publication Date
JP2024542145A JP2024542145A (ja) 2024-11-13
JP2024542145A5 true JP2024542145A5 (cg-RX-API-DMAC7.html) 2026-03-09

Family

ID=84488422

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024526929A Pending JP2024542145A (ja) 2021-11-05 2022-11-04 Prmt5阻害剤としての2-アミノイミダゾール誘導体

Country Status (5)

Country Link
US (1) US20260109709A1 (cg-RX-API-DMAC7.html)
EP (1) EP4426690A2 (cg-RX-API-DMAC7.html)
JP (1) JP2024542145A (cg-RX-API-DMAC7.html)
KR (1) KR20240157631A (cg-RX-API-DMAC7.html)
WO (1) WO2023081367A2 (cg-RX-API-DMAC7.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024038004A1 (en) 2022-08-15 2024-02-22 Astrazeneca Ab Mta-cooperative prmt5 inhibitors for use in the treatment of cancer
WO2024170488A1 (en) 2023-02-13 2024-08-22 Astrazeneca Ab Prmt5 inhibitor for use in cancer therapy
PE20260121A1 (es) 2023-04-21 2026-01-16 Gilead Sciences Inc Inhibidores de prmt5 y usos de los mismos
WO2025217007A1 (en) 2024-04-08 2025-10-16 Mirati Therapeutics, Inc. Combination therapies using prmt5 inhibitors and immune checkpoint inhibitors for the treatment of cancer
US20250312343A1 (en) 2024-04-08 2025-10-09 Mirati Therapeutics, Inc. Combination therapies using prmt5 inhibitors and kras g12d inhibitors for the treatment of cancer
US20250312351A1 (en) 2024-04-08 2025-10-09 Mirati Therapeutics, Inc. Combination therapies using prmt5 inhibitors and sos1 inhibitors for the treatment of cancer

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN120208880A (zh) * 2019-09-12 2025-06-27 米拉蒂医疗股份有限公司 Mta-协同prmt5抑制剂

Similar Documents

Publication Publication Date Title
JP7389856B2 (ja) Usp30阻害剤としての1-シアノ-ピロリジン化合物
AU2020345899B2 (en) MTA-cooperative PRMT5 inhibitors
AU2017376624B2 (en) Aminothiazole compounds as c-Kit inhibitors
CN107001339B (zh) 新化合物
AU2006330587B2 (en) Azaindole inhibitors of aurora kinases
KR100908155B1 (ko) 히스타민 h3 수용체 리간드로서 유용한테트라하이드로나프티리딘 유도체
JP2020514267A5 (cg-RX-API-DMAC7.html)
CN119173515A (zh) 泛素特异性蛋白酶1 (usp1)的小分子抑制剂和其用途
US20100022502A1 (en) Aminopyridines and aminopyrimidines useful as inhibitors of protein kinases
AU6143899A (en) Fused pyridine inhibitors of cgmp phosphodiesterase
WO2014110086A2 (en) 3-(benzoimidazol-2-yl)-indazole inhibitors of the wnt signaling pathway and therapeutic uses thereof
CN104428293A (zh) 调节TNFα的苯并咪唑类
CN104271133A (zh) 1H-吡唑并[3,4-b]吡啶及其治疗应用
AU2022307534B2 (en) Pyridinone mk2 inhibitors and uses thereof
CA2889572A1 (en) Heteroaromatic compounds as dopamine d1 ligands
JP2024542145A (ja) Prmt5阻害剤としての2-アミノイミダゾール誘導体
US12371432B2 (en) Haloallylamine compounds and application thereof
CA3171950A1 (en) Collagen 1 translation inhibitors and methods of use thereof
KR102005121B1 (ko) 2-아미노-3-(이미다졸-2-일)-피리딘-4-온 유도체 및 vegf 수용체 키나제 억제제로서의 그의 용도
US20230116201A1 (en) Collagen 1 translation inhibitors and methods of use thereof
JP2017226661A (ja) 脆弱x症候群、パーキンソン病又は逆流性疾患の治療に有用なジアゼピノン誘導体
CN118974035A (zh) 作为prmt5抑制剂的2-氨基咪唑衍生物
HK1240929B (en) Novel compounds